29 results on '"Kuipers, Maria T."'
Search Results
2. Prophylactic tocilizumab reduces the incidence of cytokine release syndrome in relapsed/refractory myeloma patients treated with teclistamab: Implications for outpatient step‐up dosing.
3. Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data
4. Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma
5. Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy
6. Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma.
7. The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands
8. P1128: EVALUATION OF STANDARD OF CARE IN SECOND-LINE FOR PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE PRE-CAR-T ERA: A DUTCH POPULATION-BASED STUDY
9. Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities
10. Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients
11. A short course of infusion of a hydrogen sulfide-donor attenuates endotoxemia induced organ injury via stimulation of anti-inflammatory pathways, with no additional protection from prolonged infusion
12. Mild hypothermia reduces ventilator–induced lung injury, irrespective of reducing respiratory rate
13. The receptor for advanced glycation end products in ventilator-induced lung injury
14. Glucose‐6‐phosphate dehydrogenase deficiency‐associated hemolysis and methemoglobinemia in a COVID‐19 patient treated with chloroquine
15. Seven-Day Vein-to-Vein Point-of-Care Manufactured CD19 CAR T Cells (GLPG5101) in Relapsed/Refractory NHL: Results from the Phase 1 Atalanta-1 Trial
16. Endogenous danger signals in ventilator-induced lung injury
17. The caspase inhibitor zVAD increases lung inflammation in pneumovirus infection in mice
18. Soluble receptor for advanced glycation end products as an indicator of pulmonary vascular injury after cardiac surgery
19. High Levels of S100A8/A9 Proteins Aggravate Ventilator-Induced Lung Injury via TLR4 Signaling
20. Hydrogen Sulfide Donor NaHS Reduces Organ Injury in a Rat Model of Pneumococcal Pneumosepsis, Associated with Improved Bio-Energetic Status
21. The Extent of Ventilator-Induced Lung Injury in Mice Partly Depends on Duration of Mechanical Ventilation
22. Pre-Treatment with Allopurinol or Uricase Attenuates Barrier Dysfunction but Not Inflammation during Murine Ventilator-Induced Lung Injury
23. Cyclin-Dependent Kinase Inhibition Reduces Lung Damage in a Mouse Model of Ventilator-Induced Lung Injury
24. Do We Need to Pay Toll on the Bridge from Innate Immunity to Ventilator-induced Diaphragm Atrophy?
25. Human Purified Protein S Reduces Neutrophil Influx In A Murine Model Of VILI
26. Ventilator-induced Lung Injury Is Mediated by the NLRP3 Inflammasome
27. Induced hypothermia is protective in a rat model of pneumococcal pneumonia associated with increased adenosine triphosphate availability and turnover*
28. Bench-to-bedside review: Damage-associated molecular patterns in the onset of ventilator-induced lung injury
29. The caspase inhibitor zVAD increases lung inflammation in pneumovirus infection in mice.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.